Steven A Shallcross insider trades: Theriva Biologics (TOVX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
and 2 more companies
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | TOVX | ↑ Buy | 14,000 | $0.69 | $10K | Direct | Jun 8, 2023 (1d) |
| Jun 6, 2023 | TOVX | ↑ Buy | 26,000 | $0.63 | $16K | Direct | Jun 7, 2023 (1d) |
| Feb 10, 2023 | TOVX | ↑ Buy | 25,000 | $1.04 | $26K | Direct | Feb 13, 2023 (3d) |
| Feb 2, 2023 | TOVX | ↑ Buy | 25,000 | $0.94 | $24K | Direct | Feb 3, 2023 (1d) |
| Jan 25, 2023 | TOVX | ↑ Buy | 25,000 | $0.87 | $22K | Direct | Jan 26, 2023 (1d) |
| Jan 20, 2023 | TOVX | ↑ Buy | 25,000 | $0.75 | $19K | Direct | Jan 23, 2023 (3d) |
| Dec 29, 2022 | TOVX | ↑ Buy | 100,000 | $0.44 | $44K | Direct | Jan 3, 2023 (5d) |
| May 10, 2021 | SYN | ↑ Buy | 50,000 | $0.49 | $25K | Direct | May 10, 2021 (0d) |
| Aug 23, 2019 | SYN | ↑ Buy | 50,000 | $0.42 | $21K | Direct | Aug 26, 2019 (3d) |
| Aug 26, 2014 | CMXI | ↑ Buy | 27,500 | $0.38 | $10K | Direct | Aug 27, 2014 (1d) |
| Aug 20, 2014 | CMXI | ↑ Buy | 52,000 | $0.39 | $20K | Direct | Aug 21, 2014 (1d) |
| Nov 28, 2007 | VNDA | ↓ Sell | 3,300 | $9.00 | $30K | Direct | Nov 30, 2007 (2d) |
| Nov 16, 2007 | VNDA | ↓ Sell | 3,300 | $25.34 | $84K | Direct | Jan 18, 2007 (0d) |
| Oct 16, 2007 | VNDA | ↓ Sell | 3,300 | $17.93 | $59K | Direct | Oct 18, 2007 (2d) |
| Sep 18, 2007 | VNDA | ↓ Sell | 3,300 | $14.81 | $49K | Direct | Sep 20, 2007 (2d) |
| Aug 21, 2007 | VNDA | ↓ Sell | 3,300 | $15.21 | $50K | Direct | Aug 23, 2007 (2d) |
| Jul 17, 2007 | VNDA | ↓ Sell | 3,300 | $20.63 | $68K | Direct | Jul 19, 2007 (2d) |
| Jun 19, 2007 | VNDA | ↓ Sell | 3,300 | $21.19 | $70K | Direct | Jun 21, 2007 (2d) |
| May 15, 2007 | VNDA | ↓ Sell | 3,300 | $19.39 | $64K | Direct | May 17, 2007 (2d) |
| Apr 17, 2007 | VNDA | ↓ Sell | 3,300 | $21.58 | $71K | Direct | Apr 19, 2007 (2d) |
| Mar 20, 2007 | VNDA | ↓ Sell | 3,300 | $23.08 | $76K | Direct | Mar 21, 2007 (1d) |
| Feb 20, 2007 | VNDA | ↓ Sell | 3,300 | $27.37 | $90K | Direct | Feb 20, 2007 (0d) |
| Dec 11, 2006 | VNDA | ↓ Sell | 10,000 | $26.45 | $265K | Direct | Dec 13, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Steven A Shallcross's insider trades
Steven A Shallcross is CEO and CFO at Theriva Biologics (TOVX). Since Dec 11, 2006, Steven has reported 11 open-market purchases worth $236K and 12 sales worth $976K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), option exercises (12 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TOVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.